Current
Neuro-Oncology


Volume 23 Number 20
October 2021


Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 20, October








Duc NM.
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma.
Contemp Oncol (Pozn). 2021;25(2):95-99. doi: 10.5114/wo.2021.105939. Online 2021 May 6. PMID: 34667435. Prospective study.




Sharieff JA, Melson A, Algan O.
Treatment of Recurrent Optic Nerve Sheath Meningioma With a Secondary Course of Radiotherapy.
Cureus. 2021 Sep 13;13(9):e17935. doi: 10.7759/cureus.17935. PMID: 34660125. Case report.




Ali S, Qasim A, Tasdique S, Sarwar MR, Shams S.
Extra-axial Desmoplastic Medulloblastoma in Adult Cerebellopontine Angle: Case Report and Noninvasive Molecular Subgrouping Utilizing Magnetic Resonance Imaging-Based Radiomics Nomogram.
Asian J Neurosurg. 2021 Sep 14;16(3):618-622. doi: 10.4103/ajns.AJNS_525_20?. PMID: 34660382. Case report.




Singh K, Garg S, Rani S, Sandhu P.
High-Grade Intraventricular Astroblastoma in a Young Adult: A Rare and Controversial Tumor to Manage.
Asian J Neurosurg. 2021 Sep 14;16(3):567-574. doi: 10.4103/ajns.AJNS_430_20?. PMID: 34660370. Case report.




Barsouk A, Baldassari MP, Khanna O, Andrews CE, Ye DY, Velagapudi L, Al Saiegh F, Hafazalla K, Cunningham E, Patel H, Malkani K, Fitchett EM, Farrell CJ, Judy KD.
Glioblastoma with deep supratentorial extension is associated with a worse overall survival.
J Clin Neurosci. 2021 Nov;93:82-87. doi: 10.1016/j.jocn.2021.08.025. Online 2021 Sep 15. PMID: 34656266. Retrospective analysis;




Lee WS, Seo SJ, Chung HK, Park JW, Kim JK, Kim EH.
Tumor-treating fields as a proton beam-sensitizer for glioblastoma therapy.
Am J Cancer Res. 2021 Sep 15;11(9):4582-4594. PMCID: PMC8493382. PMID: 34659907. Laboratory investigation.




Tseng CH.
Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Biomolecules. 2021 Sep 25;11(10):1405. doi: 10.3390/biom11101405. PMID: 34680039. Retrospective analysis.



*

Tsai HC, Wei KC, Chen PY, Huang CY, Chen KT, Lin YJ, Cheng HW, Chen YR, Wang HT.
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
Front Oncol. 2021 Oct 1;11:722754. doi: 10.3389/fonc.2021.722754. PMID: 34660288. Retrospective analysis.




Celli M, Caroli P, Amadori E, Arpa D, Gurrieri L, Ghigi G, Cenni P, Paganelli G, Matteucci F.
Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.
Front Oncol. 2021 Oct 4;11:721821. doi: 10.3389/fonc.2021.721821. PMID: 34671551. Retrospective analysis.




Cepeda S, Pérez-Nuñez A, García-García S, García-Pérez D, Arrese I, Jiménez-Roldán L, García-Galindo M, González P, Velasco-Casares M, Zamora T, Sarabia R.
Predicting Short-Term Survival after Gross Total or Near Total Resection in Glioblastomas by Machine Learning-Based Radiomic Analysis of Preoperative MRI.
Cancers (Basel). 2021 Oct 9;13(20):5047. doi: 10.3390/cancers13205047. PMID: 34680199. Retrospective analysis.




Arakawa Y, Sasaki K, Mineharu Y, Uto M, Mizowaki T, Mizusawa J, Sekino Y, Ono T, Aoyama H, Satomi K, Ichimura K, Kinoshita M, Ohno M, Ito Y, Nishikawa R, Fukuda H, Nishimura Y, Narita Y; Brain Tumor Study Group and Radiation Therapy Study Group of the Japan Clinical Oncology Group.
A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
BMC Cancer. 2021 Oct 15;21(1):1105. doi: 10.1186/s12885-021-08834-0. PMID: 34654402. Announcement.




Cluceru J, Interian Y, Phillips JJ, Molinaro AM, Luks TL, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Shai A, Chunduru P, Pedoia V, Villanueva-Meyer JE, Chang SM, Lupo JM.
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
Neuro Oncol. 2021 Oct 15:noab238. doi: 10.1093/neuonc/noab238. Online ahead of print. PMID: 34653254. Retrospective analysis;




Rudà R, Bruno F, Ius T, Silvani A, Minniti G, Pace A, Lombardi G, Bertero L, Pizzolitto S, Pollo B, Conti Nibali M, Pellerino A, Migliore E, Skrap M, Bello L, Soffietti R.
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.
Neuro Oncol. 2021 Oct 15:noab239. doi: 10.1093/neuonc/noab239. Online ahead of print. PMID: 34651653. Retrospective analysis;




Yerrabothala S, Gourley BL, Ford JC, Ahmed SR, Guerin SJ, Porter M, Wishart HA, Ernstoff MS, Fadul CE, Ornstein DL.
Systemic coagulation is activated in patients with meningioma and glioblastoma.
J Neurooncol. 2021 Oct 15. doi: 10.1007/s11060-021-03865-w. Online ahead of print. PMID: 34652553. Prospective study;




Wu C, Zheng H, Li J, Zhang Y, Duan S, Li Y, Wang D.
MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.
Eur Radiol. 2021 Oct 16. doi: 10.1007/s00330-021-08234-9. Online ahead of print. PMID: 34655310. Retrospective analysis;




Friso F, Rucci P, Rosetti V, Carretta A, Bortolotti C, Ramponi V, Martinoni M, Palandri G, Zoli M, Badaloni F, Franceschi E, Asioli S, Fabbri VP, Rustici A, Foschini MP, Brandes AA, Mazzatenta D, Sturiale C, Conti A.
Is There a Role for Surgical Resection of Multifocal Glioblastoma? A Retrospective Analysis of 100 Patients.
Neurosurgery. 2021 Oct 18:nyab345. doi: 10.1093/neuros/nyab345. Online ahead of print. PMID: 34662898. Retrospective analysis;;




Radkiewicz C, Järkvik Krönmark J, Adami HO, Edgren G.
Declining cancer incidence in the elderly: decreasing diagnostic intensity or biology?
Cancer Epidemiol Biomarkers Prev. 2021 Oct 18:cebp.0797.2021. doi: 10.1158/1055-9965.EPI-21-0797. Online ahead of print. PMID: 34663614. Retrospective analysis;



*

Liu APY, Smith KS, Kumar R, Paul L, Bihannic L, Lin T, Maass KK, Pajtler KW, Chintagumpala M, Su JM, Bouffet E, Fisher MJ, Gururangan S, Cohn R, Hassall T, Hansford JR, Klimo P Jr, Boop FA, Stewart CF, Harreld JH, Merchant TE, Tatevossian RG, Neale G, Lear M, Klco JM, Orr BA, Ellison DW, Gilbertson RJ, Onar-Thomas A, Gajjar A, Robinson GW, Northcott PA.
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Cancer Cell. 2021 Oct 19:S1535-6108(21)00501-8. doi: 10.1016/j.ccell.2021.09.012. Online ahead of print. PMID: 34678152. Prospective study;




Jajroudi M, Enferadi M, Homayoun AA, Reiazi R.
MRI-based machine learning for determining quantitative and qualitative characteristics affecting the survival of glioblastoma multiforme.
Magn Reson Imaging. 2021 Oct 20;85:222-227. doi: 10.1016/j.mri.2021.10.023. Online ahead of print. PMID: 34687850. Retrospective analysis;




Lui JCF, Tang AM, Law CC, Lee JCY, Lee FKH, Chiu J, Wong KH.
A practical methodology to improve the dosimetric accuracy of MR-based radiotherapy simulation for brain tumors.
Phys Med. 2021 Oct 20;91:1-12. doi: 10.1016/j.ejmp.2021.10.008. Online ahead of print. PMID: 34678686. Prospective study;



*

Pallud J, Huberfeld G, Dezamis E, Peeters S, Moiraghi A, Gavaret M, Guinard E, Dhermain F, Varlet P, Oppenheim C, Chrétien F, Roux A, Zanello M.
Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wildtype Glioblastoma in Adults: An Observational Study.
Neurology. 2021 Oct 21:10.1212/WNL.0000000000013005. doi: 10.1212/WNL.0000000000013005. Online ahead of print. PMID: 34675100. Observational study;




Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W.
Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Neuro Oncol. 2021 Oct 21:noab243. doi: 10.1093/neuonc/noab243. Online ahead of print. PMID: 34672349. Phase 2 trial;




Lee EJ, Lee JY, Kim JW, Phi JH, Kim YH, Kim SK, Chung HT, Wang KC, Kim DG.
Dosimetric parameters associated with the long-term oncological outcomes of Gamma Knife surgery for sellar and parasellar tumors in pediatric patients.
J Neurosurg Pediatr. 2021 Oct 22:1-9. doi: 10.3171/2021.7.PEDS21312. Online ahead of print. PMID: 34678777. Retrospective analysis;




Girard A, Le Reste PJ, Metais A, Carsin Nicol B, Chiforeanu DC, Bannier E, Campillo-Gimenez B, Devillers A, Palard-Novello X, Le Jeune F.
Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.
J Neurooncol. 2021 Oct 22. doi: 10.1007/s11060-021-03873-w. Online ahead of print. PMID: 34686993. Prospective study;




Wadiura LI, Reichert D, Sperl V, Lang A, Kiesel B, Erkkilae M, Wöhrer A, Furtner J, Roetzer T, Leitgeb R, Mischkulnig M, Widhalm G.
Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery?
J Neurosurg. 2021 Oct 22:1-9. doi: 10.3171/2021.6.JNS21940. Online ahead of print. PMID: 34678775. Prospective study;




Muir M, Patel R, Traylor JI, de Almeida Bastos DC, Kamiya C, Li J, Rao G, Prabhu SS.
Laser interstitial thermal therapy for newly diagnosed glioblastoma.
Lasers Med Sci. 2021 Oct 23. doi: 10.1007/s10103-021-03435-6. Online ahead of print. PMID: 34687390. Retrospective analysis;




Rahimy E, Dudley SA, von Eyben R, Pollom EL, Seiger K, Modlin L, Wynne J, Fujimoto D, Jacobs LR, Chang SD, Gibbs IC, Hancock SL, Adler JR, Li G, Choi CYH, Soltys SG.
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
Am J Clin Oncol. 2021 Nov 1;44(11):588-595. doi: 10.1097/COC.0000000000000868. PMID: 34670228. Phase 1/2 trial;




Jacobo JA, Vazquez-Gregorio R, Moreno-Jimenez S, Mejia-Perez S.
Decompressive craniectomy: A salvage treatment for patients with central nervous system tumors.
Cir Cir. 2021;89(5):603-610. doi: 10.24875/CIRU.20000808. Acceptance 2021 Nov 3. PMID: 34665170. Retrospective analysis.







28


***********************